Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.42.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.42.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.42.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DZ.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DZ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DZ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DZ.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DZ.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DZ.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DZ.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DZ.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.7.14.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-13753.9France
BF.7.14.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.14.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.14.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DY.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DY.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DY.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DY.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.12ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.12NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.7.14.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-13753.9France
BF.7.14.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.14.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.14.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.22ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.22ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.22ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.22NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.3.13ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.3.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.3.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.3.13NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XCUORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XCUENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XCUENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XCUNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.27.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.27.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.27.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.27.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KB.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KB.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KB.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used